vs

Side-by-side financial comparison of Sunlands Technology Group (STG) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $10.1M, roughly 1.3× Sunlands Technology Group). Sunlands Technology Group runs the higher net margin — 24.0% vs -73.9%, a 97.8% gap on every dollar of revenue. Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 0.6%).

STG Partners, LLC (STG) is an American private equity firm and based in Menlo Park, California. Its predecessor, Symphony Technology Group ("Symphony") was founded in 2002 by Romesh Wadhwani, William Chisholm, and Bryan Taylor. In 2017, Symphony was reorganized as STG Partners. As of March 2025, STG Partners managed approximately $12 billion in 19 pooled investment vehicle for its clients. The firm itself has less than one billion dollars in assets.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

STG vs TLSI — Head-to-Head

Bigger by revenue
TLSI
TLSI
1.3× larger
TLSI
$13.2M
$10.1M
STG
Higher net margin
STG
STG
97.8% more per $
STG
24.0%
-73.9%
TLSI
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
0.6%
STG

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
STG
STG
TLSI
TLSI
Revenue
$10.1M
$13.2M
Net Profit
$2.4M
$-9.8M
Gross Margin
88.5%
86.7%
Operating Margin
26.5%
-24.8%
Net Margin
24.0%
-73.9%
Revenue YoY
59.8%
Net Profit YoY
3.5%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STG
STG
TLSI
TLSI
Q4 25
$13.2M
Q3 25
$10.1M
$11.6M
Q2 25
$9.3M
$11.2M
Q1 25
$9.2M
Q4 24
$9.7M
$8.3M
Q3 24
$7.3M
Q2 24
$10.0M
$7.4M
Q1 24
$6.5M
Net Profit
STG
STG
TLSI
TLSI
Q4 25
$-9.8M
Q3 25
$2.4M
$-10.8M
Q2 25
$1.4M
$-8.3M
Q1 25
$-10.4M
Q4 24
$1.8M
$-10.1M
Q3 24
$-2.4M
Q2 24
$2.2M
$-4.3M
Q1 24
$-13.2M
Gross Margin
STG
STG
TLSI
TLSI
Q4 25
86.7%
Q3 25
88.5%
83.5%
Q2 25
85.2%
83.9%
Q1 25
83.7%
Q4 24
83.3%
85.3%
Q3 24
86.3%
Q2 24
85.2%
87.6%
Q1 24
85.0%
Operating Margin
STG
STG
TLSI
TLSI
Q4 25
-24.8%
Q3 25
26.5%
-77.9%
Q2 25
15.2%
-65.4%
Q1 25
-79.9%
Q4 24
13.4%
-91.8%
Q3 24
-118.9%
Q2 24
-111.0%
Q1 24
-180.8%
Net Margin
STG
STG
TLSI
TLSI
Q4 25
-73.9%
Q3 25
24.0%
-93.5%
Q2 25
15.4%
-73.9%
Q1 25
-113.2%
Q4 24
18.2%
-122.4%
Q3 24
-32.6%
Q2 24
21.5%
-58.8%
Q1 24
-204.5%
EPS (diluted)
STG
STG
TLSI
TLSI
Q4 25
$-0.22
Q3 25
$-0.96
Q2 25
$-0.27
Q1 25
$-0.39
Q4 24
$-0.38
Q3 24
$-0.12
Q2 24
$0.31
$-0.21
Q1 24
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STG
STG
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$15.1M
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$17.7M
$-33.9M
Total Assets
$41.2M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STG
STG
TLSI
TLSI
Q4 25
$20.4M
Q3 25
$15.1M
$22.7M
Q2 25
$26.5M
Q1 25
$13.0M
Q4 24
$15.6M
$8.5M
Q3 24
$11.3M
Q2 24
$18.7M
$16.5M
Q1 24
$4.0M
Total Debt
STG
STG
TLSI
TLSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.5M
Q3 24
Q2 24
$1.8M
Q1 24
Stockholders' Equity
STG
STG
TLSI
TLSI
Q4 25
$-33.9M
Q3 25
$17.7M
$-26.7M
Q2 25
$12.6M
$-19.4M
Q1 25
$-34.4M
Q4 24
$10.7M
$-25.9M
Q3 24
$-20.4M
Q2 24
$7.6M
$-25.3M
Q1 24
$-36.0M
Total Assets
STG
STG
TLSI
TLSI
Q4 25
$35.3M
Q3 25
$41.2M
$36.5M
Q2 25
$40.3M
$41.3M
Q1 25
$28.6M
Q4 24
$42.4M
$24.0M
Q3 24
$27.5M
Q2 24
$41.3M
$32.4M
Q1 24
$17.9M
Debt / Equity
STG
STG
TLSI
TLSI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.14×
Q3 24
Q2 24
0.24×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STG
STG
TLSI
TLSI
Operating Cash FlowLast quarter
$-2.5M
Free Cash FlowOCF − Capex
$-2.5M
FCF MarginFCF / Revenue
-19.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STG
STG
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.7M
Q2 25
$-7.3M
Q1 25
$-4.5M
Q4 24
$-5.7M
Q3 24
$-10.8M
Q2 24
$-13.4M
Q1 24
$-10.9M
Free Cash Flow
STG
STG
TLSI
TLSI
Q4 25
$-2.5M
Q3 25
$-3.9M
Q2 25
$-7.4M
Q1 25
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
STG
STG
TLSI
TLSI
Q4 25
-19.1%
Q3 25
-33.9%
Q2 25
-66.1%
Q1 25
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
STG
STG
TLSI
TLSI
Q4 25
0.3%
Q3 25
1.9%
Q2 25
0.8%
Q1 25
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons